Chengdu Easton Biopharmaceuticals (688513.SH): Injection of Vecuronium Bromide obtains Drug Registration Certificate.

Chengdu Easton Biopharmaceuticals (688513.SH) announced that the company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration. The drug is named Injection Vecuronium Bromide, with the main ingredient being Vecuronium Bromide. Indications: mainly used as an adjuvant for general anesthesia, for endotracheal intubation during general anesthesia and muscle relaxation during surgery.